After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Yahoo Finance discussed the stock recently as it posted NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Ngm Biopharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Ngm Biopharmaceuticals Inc is $130.20M. A total of 0.77 million shares were traded on the day, compared to an average of 1.11M shares.
In the most recent transaction, COLUMN GROUP L P bought 5,840 shares of NGM for 0.62 per share on Nov 16 ’23. After the transaction, the Director now owns 949,862 company shares. In a previous transaction on Nov 16 ’23, COLUMN GROUP L P bought 5,840 shares at 0.62 per share. NGM shares that Director owns now total 949,862.
Among the insiders who bought shares, COLUMN GROUP L P acquired of 5,840 shares on Nov 16 ’23 at a per-share price of $0.62. This resulted in the Director holding 949,862 shares of NGM after the transaction. In another insider transaction, GOEDDEL DAVID V bought 5,840 shares at $0.62 per share on Nov 16 ’23. Company shares held by the Director now total 949,862.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, NGM has a high of $4.69 and a low of $0.60.
As of this writing, NGM has an earnings estimate of -$0.38 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of -$0.3 per share and a lower estimate of -$0.46. The company reported an EPS of -$0.35 in the last quarter, which was 16.70% higher than expectations of -$0.42.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. NGM’s latest balance sheet shows that the firm has $366.25M in Cash & Short Term Investments as of fiscal 2021. There were $10.46M in debt and $61.35M in liabilities at the time. Its Book Value Per Share was $1.79, while its Total Shareholder’s Equity was $335.65M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NGM is Buy with a score of 3.00.
